 | • レポートコード：C-GIR20G2490 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「貧血治療薬の世界市場2019年」は、グローバルにおける貧血治療薬市場を展望するレポートです。貧血治療薬のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・貧血治療薬の市場概観 ・貧血治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・貧血治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・貧血治療薬の世界市場規模 ・貧血治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・貧血治療薬のアメリカ市場規模推移 ・貧血治療薬のカナダ市場規模推移 ・貧血治療薬のメキシコ市場規模推移 ・貧血治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・貧血治療薬のドイツ市場規模推移 ・貧血治療薬のイギリス市場規模推移 ・貧血治療薬のロシア市場規模推移 ・貧血治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・貧血治療薬の日本市場規模推移 ・貧血治療薬の中国市場規模推移 ・貧血治療薬の韓国市場規模推移 ・貧血治療薬のインド市場規模推移 ・貧血治療薬の東南アジア市場規模推移 ・貧血治療薬の南米市場分析（ブラジル、アルゼンチン等） ・貧血治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・貧血治療薬の種類別分析/販売量、売上、市場シェア（サプリメント、抗生物質、免疫抑制剤、骨髄刺激剤、コルチコステロイド、遺伝子治療、鉄キレート剤） ・貧血治療薬の用途別分析/市場規模（鉄欠乏性貧血、サラセミア、再生不良性貧血、溶血性貧血、鎌状赤血球貧血、悪性貧血） ・貧血治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・貧血治療薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Anemia Treatment Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Anemia Treatment Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Anemia Treatment Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Anemia Treatment Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
Bayer AG
AMAG Pharmaceuticals
Merck Sharp & Dohme Corp.
Amgen, Inc.
Pfizer, Inc.
Hoffmann-La Roche Ltd.
Akebia Therapeutics
Janssen Pharmaceutical
Novartis AG
GlaxoSmithKline plc
Vifor Pharma Management, Ltd.
FibroGen, Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Supplements
Antibiotics
Immunosuppressant
Bone Marrow Stimulants
Corticosteroids
Gene Therapy
Iron Chelating Agents
Market Segment by Applications, can be divided into
Iron deficiency anemia
Thalassemia
Aplastic anemia
Hemolytic anemia
Sickle cell anemia
Pernicious anemia
Table of Contents
1 Anemia Treatment Drugs Market Overview
1.1 Product Overview and Scope of Anemia Treatment Drugs
1.2 Classification of Anemia Treatment Drugs by Types
1.2.1 Global Anemia Treatment Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Anemia Treatment Drugs Revenue Market Share by Types in 2018
1.2.3 Supplements
1.2.4 Antibiotics
1.2.5 Immunosuppressant
1.2.6 Bone Marrow Stimulants
1.2.7 Corticosteroids
1.2.8 Gene Therapy
1.2.9 Iron Chelating Agents
1.3 Global Anemia Treatment Drugs Market by Application
1.3.1 Global Anemia Treatment Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Iron deficiency anemia
1.3.3 Thalassemia
1.3.4 Aplastic anemia
1.3.5 Hemolytic anemia
1.3.6 Sickle cell anemia
1.3.7 Pernicious anemia
1.4 Global Anemia Treatment Drugs Market by Regions
1.4.1 Global Anemia Treatment Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Anemia Treatment Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Anemia Treatment Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anemia Treatment Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Anemia Treatment Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anemia Treatment Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Anemia Treatment Drugs (2014-2024)
2 Company Profiles
2.1 Bayer AG
2.1.1 Business Overview
2.1.2 Anemia Treatment Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer AG Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 AMAG Pharmaceuticals
2.2.1 Business Overview
2.2.2 Anemia Treatment Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AMAG Pharmaceuticals Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Merck Sharp & Dohme Corp.
2.3.1 Business Overview
2.3.2 Anemia Treatment Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Sharp & Dohme Corp. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Amgen, Inc.
2.4.1 Business Overview
2.4.2 Anemia Treatment Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer, Inc.
2.5.1 Business Overview
2.5.2 Anemia Treatment Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 Hoffmann-La Roche Ltd.
2.6.1 Business Overview
2.6.2 Anemia Treatment Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Hoffmann-La Roche Ltd. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 Akebia Therapeutics
2.7.1 Business Overview
2.7.2 Anemia Treatment Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Akebia Therapeutics Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.8 Janssen Pharmaceutical
2.8.1 Business Overview
2.8.2 Anemia Treatment Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Janssen Pharmaceutical Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.9 Novartis AG
2.9.1 Business Overview
2.9.2 Anemia Treatment Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Novartis AG Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.10 GlaxoSmithKline plc
2.10.1 Business Overview
2.10.2 Anemia Treatment Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GlaxoSmithKline plc Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.11 Vifor Pharma Management, Ltd.
2.11.1 Business Overview
2.11.2 Anemia Treatment Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Vifor Pharma Management, Ltd. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.12 FibroGen, Inc.
2.12.1 Business Overview
2.12.2 Anemia Treatment Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 FibroGen, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Anemia Treatment Drugs Market Competition, by Players
3.1 Global Anemia Treatment Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Anemia Treatment Drugs Players Market Share
3.2.2 Top 10 Anemia Treatment Drugs Players Market Share
3.3 Market Competition Trend
4 Global Anemia Treatment Drugs Market Size by Regions
4.1 Global Anemia Treatment Drugs Revenue and Market Share by Regions
4.2 North America Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
5 North America Anemia Treatment Drugs Revenue by Countries
5.1 North America Anemia Treatment Drugs Revenue by Countries (2014-2019)
5.2 USA Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
6 Europe Anemia Treatment Drugs Revenue by Countries
6.1 Europe Anemia Treatment Drugs Revenue by Countries (2014-2019)
6.2 Germany Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
6.4 France Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Anemia Treatment Drugs Revenue by Countries
7.1 Asia-Pacific Anemia Treatment Drugs Revenue by Countries (2014-2019)
7.2 China Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
7.5 India Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
8 South America Anemia Treatment Drugs Revenue by Countries
8.1 South America Anemia Treatment Drugs Revenue by Countries (2014-2019)
8.2 Brazil Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Anemia Treatment Drugs by Countries
9.1 Middle East and Africa Anemia Treatment Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
10 Global Anemia Treatment Drugs Market Segment by Type
10.1 Global Anemia Treatment Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Anemia Treatment Drugs Market Forecast by Type (2019-2024)
10.3 Supplements Revenue Growth Rate (2014-2024)
10.4 Antibiotics Revenue Growth Rate (2014-2024)
10.5 Immunosuppressant Revenue Growth Rate (2014-2024)
10.6 Bone Marrow Stimulants Revenue Growth Rate (2014-2024)
10.7 Corticosteroids Revenue Growth Rate (2014-2024)
10.8 Gene Therapy Revenue Growth Rate (2014-2024)
10.9 Iron Chelating Agents Revenue Growth Rate (2014-2024)
11 Global Anemia Treatment Drugs Market Segment by Application
11.1 Global Anemia Treatment Drugs Revenue Market Share by Application (2014-2019)
11.2 Anemia Treatment Drugs Market Forecast by Application (2019-2024)
11.3 Iron deficiency anemia Revenue Growth (2014-2019)
11.4 Thalassemia Revenue Growth (2014-2019)
11.5 Aplastic anemia Revenue Growth (2014-2019)
11.6 Hemolytic anemia Revenue Growth (2014-2019)
11.7 Sickle cell anemia Revenue Growth (2014-2019)
11.8 Pernicious anemia Revenue Growth (2014-2019)
12 Global Anemia Treatment Drugs Market Size Forecast (2019-2024)
12.1 Global Anemia Treatment Drugs Market Size Forecast (2019-2024)
12.2 Global Anemia Treatment Drugs Market Forecast by Regions (2019-2024)
12.3 North America Anemia Treatment Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Anemia Treatment Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Anemia Treatment Drugs Revenue Market Forecast (2019-2024)
12.6 South America Anemia Treatment Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Anemia Treatment Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Anemia Treatment Drugs Picture
Table Product Specifications of Anemia Treatment Drugs
Table Global Anemia Treatment Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Anemia Treatment Drugs Revenue Market Share by Types in 2018
Figure Supplements Picture
Figure Antibiotics Picture
Figure Immunosuppressant Picture
Figure Bone Marrow Stimulants Picture
Figure Corticosteroids Picture
Figure Gene Therapy Picture
Figure Iron Chelating Agents Picture
Table Global Anemia Treatment Drugs Revenue (Million USD) by Application (2014-2024)
Figure Anemia Treatment Drugs Revenue Market Share by Applications in 2018
Figure Iron deficiency anemia Picture
Figure Thalassemia Picture
Figure Aplastic anemia Picture
Figure Hemolytic anemia Picture
Figure Sickle cell anemia Picture
Figure Pernicious anemia Picture
Table Global Market Anemia Treatment Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Bayer AG Basic Information, Manufacturing Base and Competitors
Table Bayer AG Anemia Treatment Drugs Type and Applications
Table Bayer AG Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table AMAG Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table AMAG Pharmaceuticals Anemia Treatment Drugs Type and Applications
Table AMAG Pharmaceuticals Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Sharp & Dohme Corp. Basic Information, Manufacturing Base and Competitors
Table Merck Sharp & Dohme Corp. Anemia Treatment Drugs Type and Applications
Table Merck Sharp & Dohme Corp. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen, Inc. Basic Information, Manufacturing Base and Competitors
Table Amgen, Inc. Anemia Treatment Drugs Type and Applications
Table Amgen, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer, Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer, Inc. Anemia Treatment Drugs Type and Applications
Table Pfizer, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table Hoffmann-La Roche Ltd. Anemia Treatment Drugs Type and Applications
Table Hoffmann-La Roche Ltd. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Akebia Therapeutics Basic Information, Manufacturing Base and Competitors
Table Akebia Therapeutics Anemia Treatment Drugs Type and Applications
Table Akebia Therapeutics Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Janssen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Janssen Pharmaceutical Anemia Treatment Drugs Type and Applications
Table Janssen Pharmaceutical Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Anemia Treatment Drugs Type and Applications
Table Novartis AG Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline plc Anemia Treatment Drugs Type and Applications
Table GlaxoSmithKline plc Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Vifor Pharma Management, Ltd. Basic Information, Manufacturing Base and Competitors
Table Vifor Pharma Management, Ltd. Anemia Treatment Drugs Type and Applications
Table Vifor Pharma Management, Ltd. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table FibroGen, Inc. Basic Information, Manufacturing Base and Competitors
Table FibroGen, Inc. Anemia Treatment Drugs Type and Applications
Table FibroGen, Inc. Anemia Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Anemia Treatment Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Anemia Treatment Drugs Revenue Share by Players (2014-2019)
Figure Global Anemia Treatment Drugs Revenue Share by Players in 2017
Figure Global Anemia Treatment Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Anemia Treatment Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Anemia Treatment Drugs Revenue Market Share in 2018
Figure Global Anemia Treatment Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Anemia Treatment Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Anemia Treatment Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Anemia Treatment Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Anemia Treatment Drugs Revenue Market Share by Regions in 2018
Figure North America Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure South America Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Table North America Anemia Treatment Drugs Revenue by Countries (2014-2019)
Table North America Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Anemia Treatment Drugs Revenue Market Share by Countries in 2018
Figure USA Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Table Europe Anemia Treatment Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Anemia Treatment Drugs Revenue Market Share by Countries in 2018
Figure Germany Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure UK Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure France Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Anemia Treatment Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Anemia Treatment Drugs Revenue Market Share by Countries in 2018
Figure China Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure India Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Table South America Anemia Treatment Drugs Revenue by Countries (2014-2019)
Table South America Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Anemia Treatment Drugs Revenue Market Share by Countries in 2018
Figure Brazil Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Anemia Treatment Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anemia Treatment Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anemia Treatment Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Anemia Treatment Drugs Revenue and Growth Rate (2014-2019)
Table Global Anemia Treatment Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Anemia Treatment Drugs Revenue Share by Type (2014-2019)
Figure Global Anemia Treatment Drugs Revenue Share by Type (2014-2019)
Figure Global Anemia Treatment Drugs Revenue Share by Type in 2018
Table Global Anemia Treatment Drugs Revenue Forecast by Type (2019-2024)
Figure Global Anemia Treatment Drugs Market Share Forecast by Type (2019-2024)
Figure Global Supplements Revenue Growth Rate (2014-2019)
Figure Global Antibiotics Revenue Growth Rate (2014-2019)
Figure Global Immunosuppressant Revenue Growth Rate (2014-2019)
Figure Global Bone Marrow Stimulants Revenue Growth Rate (2014-2019)
Figure Global Corticosteroids Revenue Growth Rate (2014-2019)
Figure Global Gene Therapy Revenue Growth Rate (2014-2019)
Figure Global Iron Chelating Agents Revenue Growth Rate (2014-2019)
Table Global Anemia Treatment Drugs Revenue by Application (2014-2019)
Table Global Anemia Treatment Drugs Revenue Share by Application (2014-2019)
Figure Global Anemia Treatment Drugs Revenue Share by Application (2014-2019)
Figure Global Anemia Treatment Drugs Revenue Share by Application in 2018
Table Global Anemia Treatment Drugs Revenue Forecast by Application (2019-2024)
Figure Global Anemia Treatment Drugs Market Share Forecast by Application (2019-2024)
Figure Global Iron deficiency anemia Revenue Growth Rate (2014-2019)
Figure Global Thalassemia Revenue Growth Rate (2014-2019)
Figure Global Aplastic anemia Revenue Growth Rate (2014-2019)
Figure Global Hemolytic anemia Revenue Growth Rate (2014-2019)
Figure Global Sickle cell anemia Revenue Growth Rate (2014-2019)
Figure Global Pernicious anemia Revenue Growth Rate (2014-2019)
Figure Global Anemia Treatment Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Anemia Treatment Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Anemia Treatment Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Anemia Treatment Drugs Revenue Market Forecast (2019-2024)
Figure Europe Anemia Treatment Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Anemia Treatment Drugs Revenue Market Forecast (2019-2024)
Figure South America Anemia Treatment Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Anemia Treatment Drugs Revenue Market Forecast (2019-2024)
世界の貧血治療市場予測（～2024年） Anemia is a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood,[3][4] or a lowered ability of the blood to carry oxygen.[5] When anemia comes on slowly, the symptoms are often vague and may include feeling tired, weakness, shortness of breath or a poor ability to exerc…- 世界の腎性貧血治療市場予測（～2024年）：メーカー別、地域別、種類・用途別 Anemia is a common complication of CKD, typically occurring early in the development of the disease and becoming more severe as CKD progresses. The primary treatment goal in renal anemia is to increase and maintain hemoglobin and other anemia parameters, such as ferritin. Scope of the Report: The wo…
- 副鼻腔炎治療薬の世界市場 2019年版：種類別（抗生物質、NSAIDS、充血除去剤および粘液溶解剤、鼻洗浄キット）、用途別（病院、診療所、その他） Scope of the Report: The global Sinusitis Treatment Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China,…
- 不眠症治療薬の世界市場 2019年版：種類別（処方睡眠補助薬、市販薬（OTC）睡眠補助薬）、用途別（病院、薬局、その他） Scope of the Report: The global Insomnia Treatment Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, …
- 性器ヘルペス治療薬の世界市場 2019年版：種類別（アシクロビル、ファムシクロビル、バラシクロビル）、用途別（病院、診療所、その他） Scope of the Report: The global Genital Herpes Treatment Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in C…